About Soren Mogelsvang
Form D filings for Exxel Pharma in 2024 list Soren Mogelsvang as CEO and director.
Soren Mogelsvang first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Soren Mogelsvang in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Soren Mogelsvang works with at each company, as listed on that company's latest Form D.
Exxel Pharma, INC. · Form D, Dec 2, 2024
GY
Guy Yachin
Director